Glenmede Investment Management, LP Guardant Health, Inc. Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Glenmede Investment Management, LP holds 4,529 shares of GH stock, worth $427,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,529
Previous 4,054
11.72%
Holding current value
$427,401
Previous $211 Million
99.87%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
450Shares Held
125MCall Options Held
2.18MPut Options Held
2.69M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.12 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$484 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$465 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$443 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.65B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...